Retatrutide 80mg*10vials

描述

Core Features
$\ge 99.0\%$ Ultra-High Purity & Industrial-Scale Quality Control: This product is manufactured using industry-leading automated high-throughput solid-phase peptide synthesis (SPPS) technology. Given Retatrutide’s complex heterogeneous peptide chain structure and its high 80mg-per-vial dosage, the synthesis process presents significant challenges regarding intermediate temperature control and final desalting/purification. We employ precise industrial-scale reversed-phase preparative HPLC (RP-HPLC) to rigorously eliminate by-products such as racemates, truncated chains, and mis-sequences. Each 80mg vial guarantees a baseline purity of $\ge 99.0\%$, providing a clean, interference-free matrix for large-scale in vitro receptor affinity assays and long-term in vivo animal metabolic model studies.
Synergistic Triple-Agonist Mechanism: Retatrutide is a standout molecule in metabolic research, capable of binding with high affinity to three key metabolic receptors: GIPR (glucose-dependent insulinotropic polypeptide receptor), GLP-1R (glucagon-like peptide-1 receptor), and GCGR (glucagon receptor). Its unique triple-agonist structure makes it an indispensable tool for investigating mechanisms involving the synergistic downregulation of appetite, delayed gastric emptying, the browning of white adipose tissue, and the upregulation of overall energy expenditure.
Advanced Cryo-Lyophilization Process: Moisture sublimation of the high-concentration (80mg) peptide powder occurs at ultra-low temperatures ($-80^\circ\text{C}$) and near-absolute vacuum, resulting in a uniform, robust, and collapse-free “lyophilized cake” with a snowflake-like crystalline structure. This process not only ensures excellent reconstitution properties—allowing for dissolution within seconds using sterile water for injection or normal saline, resulting in a clear, bubble-free solution—but also stabilizes the molecule at the level of its secondary structure. This significantly mitigates the risks of thermal degradation and conformational loss during international transit and prolonged customs clearance.

🛠️ Technical Specifications & Parameters
Parameter | Specification Details
Product Specification | 80 mg / Vacuum-Sealed Glass Vial
Molecular Formula | $\text{C}_{211}\text{H}_{342}\text{N}_{54}\text{O}_{68}$
Appearance | White to off-white sterile lyophilized powder or intact solid cake
Validation | Accompanied by original manufacturer HPLC purity chromatograms and MS molecular weight verification reports (one certificate per vial; supports digital traceability and batch verification against manufacturer records).

❄️ Storage Requirements & Comprehensive Cold Chain Protection
Laboratory Storage Protocol: Upon receipt, the product must be stored immediately in its unreconstituted state within an explosion-proof, research-grade ultra-low temperature freezer ($-20^\circ\text{C}$ to $-80^\circ\text{C}$), ensuring protection from light and moisture while maintaining a high-vacuum seal. Storage in standard household appliances or administrative office equipment lacking temperature logging capabilities is strictly prohibited. Given the large 80 mg fill volume and the product’s susceptibility to degradation post-reconstitution, researchers are strongly advised to aliquot the solution into single-experiment doses and freeze them to create a standardized master stock; repeated freeze-thaw cycles are strictly prohibited.
Pharmaceutical-Grade Cold Chain Shipping: Strictly adheres to the platform’s “International Shipping and Order Scheduling” policy. For the shipment of 80mg Retatrutide, we utilize high-density, thickened five-layer insulated foam boxes paired with high-capacity, factory-grade phase-change gel packs via express delivery. This ensures that the peptide molecules remain in a “locked-in” state—preserving their complex spatial conformation—while traversing diverse global climate zones.

📝 Scientific Compliance & Disclaimer (Research Limitations & Compliance)
⚠️ Strictly for Laboratory Research Use Only (RUO): This product (Retatrutide 80mg) is a chemical reagent intended for cutting-edge life science research. In strict adherence to global biosafety and compliance standards, its use is restricted to academic research within university laboratories, research institutes, or R&D centers of biopharmaceutical companies (e.g., cell receptor binding affinity assays, high-throughput drug screening, long-term metabolic cohort monitoring in large animal models). Any unauthorized human clinical use—including injection, oral administration, substitution for prescribed medication, or use as an illicit weight-loss agent or performance-enhancing drug—is strictly prohibited. This platform enforces a rigorous multi-level review process regarding the “End-Use Statement”; any orders suspected of misuse will be unconditionally cancelled and reported to the relevant compliance authorities.